Click here to view a printable PDF of our Pancreas Program brochure.
Pancreatic and biliary disorders can be among the most challenging gastrointestinal conditions to diagnose and treat, and they are becoming more and more common. The good news is that using advanced diagnostic and therapeutic technologies and techniques, some of these conditions can be prevented and cured, while others can be successfully managed. The Program in Pancreas and Biliary Disorders at Capital Health offers a multidisciplinary approach to optimize not only the care patients will receive, but also to better coordinate their care with referring physicians, medical oncologists, and other providers.
Our expert physicians have dedicated extra years to specialized training in these techniques and technologies, including advanced therapeutic gastrointestinal endoscopy and minimally invasive surgery.
Diseases/conditions treated include (but are not limited to):
- Pancreatic cancer
- Pancreatic cysts
- Pancreatic neuroendocrine tumors
- Abdominal/back pain caused by pancreas or bile duct cancer
- Acute pancreatitis
- Chronic pancreatitis
- Autoimmune pancreatitis
- Pancreatic pseudocyst
- Cholangiocarcinoma (bile duct cancer)
- Bile duct stones
- Gallbladder stones
- Bile duct strictures
- Bile leaks
State-of-the-art endoscopic technology and treatments:
- Biliary radiofrequency ablation for the palliation of non-resectable cholangiocarcinoma and malignant bile duct strictures
- Endoscopic ultrasound (EUS)
- EUS with fine needle aspiration (FNA)
- Endoscopic retrograde cholangiopancreatography (ERCP)
- Cholangioscopy (SpyGlass® Direct Visualization System)
- Celiac plexus nerve block and neurolysis
- Pancreatic pseudocyst drainage
Clinical Research and Education
As part of the Center’s mission to improve patient care and remain on the cutting edge of technology, our physicians are continually involved in clinical research and education. All procedures, however, are performed only by the attending interventional gastroenterologist, without trainee involvement. Our interventional gastroenterologist, Dr. Jason Rogart, is often among the first to trial new equipment before or right after it becomes commercially available, and he has published numerous studies in the most prestigious medical journals in gastroenterology and surgery, as well as published numerous book chapters.
Dr. Jason Rogart
Rogart JN, Loren DE, Signu BS, Kowalski TE. Cyst Wall Puncture and Aspiration during EUS-guided Fine Needle Aspiration May Increase the Diagnostic Yield of Mucinous Cysts of the Pancreas. Journal of Clinical Gastroenterology2011 Feb;45(2):164-9.
Rogart JN. The Plastic Biliary Stent: An Obsolete Device for Managing Pancreatic Cancer? (editorial) Journal of Clinical Gastroenterology2010 Jul;44(6):389-90.
Rogart JN, Israel G, Jamidar P. Cystic duct stumpyemamanaged endoscopically. Clinical Gastroenterology &Hepatology2009 Aug;7(8):e43-4.
Rogart JN and Aslanian HR. Massive hemobilia after transjugular liver biopsy treated endoscopically and angiographically. Clinical Gastroenterology &Hepatology2008;6(12):A30.
Rogart JN, Boghos A, Rossi F, Al-Hashem H, Siddiqui UD, Jamidar P, Aslanian H. Analysis of endoscopic management of occluded metal biliary stents at a single tertiary care center. Gastrointestinal Endoscopy2008;68(4):676-682.
Rogart JN and Loren DE. Balloon Sphincteroplasty and Post-Sphincterotomy Balloon Dilation. In: Monkemuller K, Miguel Muñoz-Navas, Mel Wilcox and Todd Baron, eds. Interventional Therapeutic Endoscopy (Karger Publishing, Basel, Switzerland, 2010)
Loren, DE, Kavanaugh B, Kowalski TE, Etemad B, and Rogart JN. Section X: Pancreas and Biliary Diseases. In: Sleisenger and Fordtran’s Gastrointestinal and Liver Disease: Review and Assessment, 9th ed. DiMarino AJ, ed. (Saunders, 2010)
Niedenthal A, Dancygier H, Rogart J. EndoscopicUltrasonography (chapter 42). In: Dancygier H, ed. Clinical Hepatology: principles and practice of hepatobiliary diseases (Springer, 2010).
Rogart J, Stenscheke F.Cholangioscopy (chapter 41). In: Dancygier H, ed. Clinical Hepatology: principles and practice of hepatobiliary diseases (Springer, 2010).
Stenschke F, Dancygier H, Rogart J. Endoscopic Retrograde and Percutaneous Transhepatic Cholangiography (chapter 40). In: Dancygier H, ed. Clinical Hepatology: principles and practice of hepatobiliary diseases (Springer, 2010).
Dancygier H, Rogart J. Evaluation of the patient with hepatobiliary disease: History (chapter 31). In: Dancygier H, ed. Clinical Hepatology: principles and practice of hepatobiliary diseases (Springer, 2010).
Dancygier H, Rogart J. Approach to the Patient with Cholestasis and Jaundice(chapter 52).In: Dancygier H, ed. Clinical Hepatology: principles and practice of hepatobiliary diseases (Springer, 2010).
Lee DS, Kwok K, Gannon C, and Rogart J.Busulfan-associated asymptomatic type I Mirizzi’s Syndrome. American Journal of Gastroenterology 2010;105(S1):AB543; Presentation at ACG Annual Meeting 2010, San Antonio.
Rogart JN, Orfanidis N, Korenblit J, Coben R, Infantolino A, Kowalski TE, loren DE. Incremental diagnostic yield of on-site quick-prep smear versus cell-block cytology in EUS-FNA of solid and cystic masses.American Journal of Gastroenterology 2009;104(S3):AB152; Presentation at ACG Annual Meeting 2009, San Diego.